代謝物質化学試薬:医療機器パイプライン分析2017

GlobalDataが発行した調査報告書(GDME0427EPD)
◆英語タイトル:Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0427EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月1日
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Metabolite Chemistry Reagents – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Metabolite Chemistry Reagents – Medical Devices Pipeline Assessment, 2017″ provides an overview of Metabolite Chemistry Reagents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Metabolite Chemistry Reagents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Metabolite Chemistry Reagents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Metabolite Chemistry Reagents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Metabolite Chemistry Reagents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Metabolite Chemistry Reagents Overview 6
3 Products under Development 7
3.1 Metabolite Chemistry Reagents – Pipeline Products by Stage of Development 7
3.2 Metabolite Chemistry Reagents – Pipeline Products by Territory 8
3.3 Metabolite Chemistry Reagents – Pipeline Products by Regulatory Path 9
4 Metabolite Chemistry Reagents – Pipeline Products under Development by Companies 10
4.1 Metabolite Chemistry Reagents Companies – Pipeline Products by Stage of Development 10
4.2 Metabolite Chemistry Reagents – Pipeline Products by Stage of Development 11
5 Metabolite Chemistry Reagents Companies and Product Overview 12
5.1 A/C Diagnostics LLC Company Overview 12
5.1.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Advanced Liquid Logic Inc Company Overview 13
5.2.1 Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 14
5.3.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 Analyticon Biotechnologies AG Company Overview 15
5.4.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 BG Medicine Inc Company Overview 33
5.5.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Genesis Detection Systems, Inc. Company Overview 34
5.6.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Healthmed Services Ltd. (Inactive) Company Overview 35
5.7.1 Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
5.8 Instrumentation Laboratory Company Company Overview 36
5.8.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 36
5.9 iXensor Co. Ltd. Company Overview 37
5.9.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
5.10 Luminor Medical Technologies Inc Company Overview 38
5.10.1 Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Ohmx Corp Company Overview 39
5.11.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Siemens Healthcare GmbH Company Overview 40
5.12.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 The Binding Site Group Ltd Company Overview 41
5.13.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Versantis AG Company Overview 42
5.14.1 Versantis AG Pipeline Products & Ongoing Clinical Trials Overview 42
6 Metabolite Chemistry Reagents- Recent Developments 43
6.1 Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 43
6.2 Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 44
6.3 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 45
6.4 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 47
6.5 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 50
6.6 Jul 03, 2017: Premaitha Health Litigation Update 50
6.7 Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 51
6.8 May 22, 2017: Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role 52
6.9 May 18, 2017: Aalto Bio Reagents Launches West Nile Virus Native and Recombinant Proteins for Diagnostic Testing 52
6.10 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 53
6.11 May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 55
6.12 Apr 25, 2017: Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 56
6.13 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 57
6.14 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 60
6.15 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 60
6.16 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston 61
6.17 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 62
6.18 Mar 20, 2017: EKF Diagnostics Holdings: Final results 62
6.19 Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 63
6.20 Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 63
6.21 Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 63
6.22 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 64
6.23 Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 66
6.24 Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 67
6.25 Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 68
6.26 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 68
6.27 Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 69
6.28 Jan 03, 2017: Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit 69
6.29 Dec 22, 2016: Bionaturis Group gets a new patent in USA innovating in the use of natural resources to produce pharmaceutical products 70
6.30 Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team 70
6.31 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 70
6.32 Dec 14, 2016: Siemens Healthineers to significantly expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility 71
6.33 Dec 07, 2016: Illumina appoints senior vice president and CFO 72
6.34 Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer 72
6.35 Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 73
6.36 Nov 01, 2016: Oxford Immunotec Reports Third Quarter 2016 Financial Results 73
6.37 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 75
6.38 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 76
6.39 Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update 79
6.40 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 81
6.41 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 83
6.42 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 84
7 Appendix 87
7.1 Methodology 87
7.2 About GlobalData 90
7.3 Contact Us 90
7.4 Disclaimer 90

1.1 List of Tables
Table 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 7
Table 2: Metabolite Chemistry Reagents - Pipeline Products by Territory 8
Table 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path 9
Table 4: Metabolite Chemistry Reagents Companies - Pipeline Products by Stage of Development 10
Table 5: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 11
Table 6: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 12
Table 7: Folate Enzymatic Assay - Product Status 12
Table 8: Folate Enzymatic Assay - Product Description 12
Table 9: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 10: Total Serum Biliruibin Multiplex Assay - Product Status 13
Table 11: Total Serum Biliruibin Multiplex Assay - Product Description 13
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 13: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Status 14
Table 14: ACE Alera Clinical Chemistry System - Neonatal Bilirubin Assay - Product Description 14
Table 15: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
Table 16: BIL-Direct JG Fluitest - Product Status 16
Table 17: BIL-Direct JG Fluitest - Product Description 16
Table 18: BIL-Total JG Fluitest - Product Status 16
Table 19: BIL-Total JG Fluitest - Product Description 17
Table 20: BIL-Total VBM Fluitest - Product Status 17
Table 21: BIL-Total VBM Fluitest - Product Description 17
Table 22: BIL-Total WG Fluitest - Product Status 18
Table 23: BIL-Total WG Fluitest - Product Description 18
Table 24: BILD-DCA Fluitest - Product Status 18
Table 25: BILD-DCA Fluitest - Product Description 19
Table 26: BILT-DCA Fluitest - Product Status 19
Table 27: BILT-DCA Fluitest - Product Description 19
Table 28: CHOL - HDL Direct Fluitest - Product Status 20
Table 29: CHOL - HDL Direct Fluitest - Product Description 20
Table 30: CHOL - LDL Direct Fluitest - Product Status 20
Table 31: CHOL - LDL Direct Fluitest - Product Description 21
Table 32: CHOL - LDL Fluitest - Product Status 21
Table 33: CHOL - LDL Fluitest - Product Description 21
Table 34: CHOL CHOD-PAP Lyophilisat - Product Status 22
Table 35: CHOL CHOD-PAP Lyophilisat - Product Description 22
Table 36: CHOL Fluitest - Product Status 22
Table 37: CHOL Fluitest - Product Description 23
Table 38: Fluitest ALB-BCG - Product Status 23
Table 39: Fluitest ALB-BCG - Product Description 23
Table 40: Fluitest BIL - Direct Walters/Gerarde - Product Status 24
Table 41: Fluitest BIL - Direct Walters/Gerarde - Product Description 24
Table 42: Fluitest BIL T/D - Product Status 24
Table 43: Fluitest BIL T/D - Product Description 25
Table 44: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Status 25
Table 45: Fluitest CHOL-HDL Phosphotungstic Acid/Magnesium Chloride - Product Description 25
Table 46: Fluitest CREA - Kinetic - Product Status 26
Table 47: Fluitest CREA - Kinetic - Product Description 26
Table 48: Fluitest FE FZ - Product Status 26
Table 49: Fluitest FE FZ - Product Description 27
Table 50: Fluitest FRUC - Product Status 27
Table 51: Fluitest FRUC - Product Description 28
Table 52: Fluitest GLU GOD-PAP - Product Status 28
Table 53: Fluitest GLU GOD-PAP - Product Description 28
Table 54: Fluitest LA PAP - Product Status 29
Table 55: Fluitest LA PAP - Product Description 29
Table 56: GLU GOD - PAP Lyophilisat - Product Status 29
Table 57: GLU GOD - PAP Lyophilisat - Product Description 30
Table 58: HbA1 Ion Exchange Batch Assay - Product Status 30
Table 59: HbA1 Ion Exchange Batch Assay - Product Description 30
Table 60: HbA1c Micro Column Assay - Product Status 31
Table 61: HbA1c Micro Column Assay - Product Description 31
Table 62: Turbitex FER - Product Status 31
Table 63: Turbitex FER - Product Description 32
Table 64: Turbitex HbA1c/Hb Assay - Product Status 32
Table 65: Turbitex HbA1c/Hb Assay - Product Description 32
Table 66: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 67: LipidDx - Product Status 33
Table 68: LipidDx - Product Description 33
Table 69: Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 70: Rapid Home Test - HDL/LDL Cholesterol - Product Status 34
Table 71: Rapid Home Test - HDL/LDL Cholesterol - Product Description 34
Table 72: Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
Table 73: Glycated Albumin Test - Product Status 35
Table 74: Glycated Albumin Test - Product Description 35
Table 75: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 36
Table 76: GEM Premier 4000 Analyzer - BUN - Product Status 36
Table 77: GEM Premier 4000 Analyzer - BUN - Product Description 36
Table 78: iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 79: Uric Acid Test - Product Status 37
Table 80: Uric Acid Test - Product Description 37
Table 81: Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 82: Next Generation PreVu LP Test - Product Status 38
Table 83: Next Generation PreVu LP Test - Product Description 38
Table 84: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 39
Table 85: Diagnostic Test - FAD Metabolite - Product Status 39
Table 86: Diagnostic Test - FAD Metabolite - Product Description 39
Table 87: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
Table 88: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Status 40
Table 89: ADVIA 1800 Chemistry System - Creatinine Validity Test - Product Description 40
Table 90: The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 91: Albumin Urine SPAplus Kit - Product Status 41
Table 92: Albumin Urine SPAplus Kit - Product Description 41
Table 93: Versantis AG Pipeline Products & Ongoing Clinical Trials Overview 42
Table 94: TS-01 - Product Status 42
Table 95: TS-01 - Product Description 42
Table 96: Glossary 89

1.2 List of Figures
Figure 1: Metabolite Chemistry Reagents - Pipeline Products by Stage of Development 7
Figure 2: Metabolite Chemistry Reagents - Pipeline Products by Territory 8
Figure 3: Metabolite Chemistry Reagents - Pipeline Products by Regulatory Path 9

【掲載企業】

A/C Diagnostics LLC
Advanced Liquid Logic Inc
Alfa Wassermann Diagnostic Technologies, LLC
Analyticon Biotechnologies AG
BG Medicine Inc
Genesis Detection Systems, Inc.
Healthmed Services Ltd.
Instrumentation Laboratory Company
iXensor Co. Ltd.
Luminor Medical Technologies Inc
Ohmx Corp
Siemens Healthcare GmbH
The Binding Site Group Ltd
Versantis AG

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 代謝物質化学試薬:医療機器パイプライン分析2017(Metabolite Chemistry Reagents - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆